The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature Biotechnology

• Publication date

  2006-11-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nbt1256PMID 17115055PMCID PMC9338427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microbial Disease in Humans: A Genomic Perspective

  2012cited by this paper
• The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome

  2006cited by this paper
• The use of clostridial spores for cancer treatment

  2006cited by this paper
• A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs

  2006cited by this paper
• The forespore line of gene expression in Bacillus subtilis.

  2006cited by this paper
• When should one subtract background fluorescence in 2-color microarrays?

  2006cited by this paper
• Use of bacteria in anti-cancer therapies.

  2006cited by this paper
• Genome Sequence of the PCE-Dechlorinating Bacterium Dehalococcoides ethenogenes

  2005cited by this paper
• How genomics has affected the concept of microbiology.

  2005cited by this paper
• Transcriptional Program of Early Sporulation and Stationary-Phase Events in Clostridium acetobutylicum

  2005cited by this paper
• Towards a prokaryotic genomic taxonomy.

  2005cited by this paper
• Pharmacologic and toxicologic evaluation of C. novyi-NT spores.

  2005cited by this paper
• limma: Linear Models for Microarray Data

  2005cited by this paper
• New wrinkles and folds in site-specific recombination.

  2005cited by this paper
• Bacterial ribosomal RNA in pieces

  2005cited by this paper
• Bacteriolytic therapy can generate a potent immune response against experimental tumors.

  2004cited by this paper
• Targeting Vascular and Avascular Compartments of Tumors with C. novyi-NT and Anti-microtubule Agents

  2004cited by this paper
• Formation and Composition of the Bacillus anthracis Endospore

  2004cited by this paper
• Colorectal carcinoma in endoscopic biopsies; additional histologic criteria for the diagnosis.

  2004cited by this paper
• The Analysis of Gene Expression Data

  2003cited by this paper
• Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria

  2003cited by this paper
• The genome sequence of Clostridium tetani, the causative agent of tetanus disease

  2003cited by this paper
• Bacteria as tumour-targeting vectors.

  2003cited by this paper
• PCR-assisted contig extension: stepwise strategy for bacterial genome closure.

  2003cited by this paper
• Tumor-specific gene delivery using genetically engineered bacteria.

  2003cited by this paper
• Clostridia in cancer therapy

  2003cited by this paper
• Spore germination.

  2003cited by this paper
• Gene expression analysis using oligonucleotide arrays produced by maskless photolithography.

  2002cited by this paper
• Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater

  2002cited by this paper
• Genome Sequence and Comparative Analysis of the Solvent-Producing Bacterium Clostridium acetobutylicum

  2001cited by this paper
• Combination bacteriolytic therapy for the treatment of experimental tumors

  2001cited by this paper
• The glutathione peroxidases

  2001cited by this paper
• Can engineered bacteria help control cancer?

  2001cited by this paper
• Microbial disease in humans: A genomic perspective.

  2001cited by this paper
• The transcriptional profile of early to middle sporulation in Bacillus subtilis.

  2000cited by this paper
• Isolation of a 250 million-year-old halotolerant bacterium from a primary salt crystal

  2000cited by this paper
• The Clostridium perfringens alpha-toxin.

  1999cited by this paper
• Regulation of initiation of Bacillus subtilis chromosome replication.

  1999cited by this paper
• Regulation of Initiation ofBacillus subtilisChromosome Replication

  1999cited by this paper
• The Clostridium perfringensα-toxin

  1999cited by this paper
• Bacterial biocatalysts: molecular biology, three-dimensional structures, and biotechnological applications of lipases.

  1999cited by this paper
• Consed: a graphical tool for sequence finishing.

  1998cited by this paper
• Base-calling of automated sequencer traces using phred. I. Accuracy assessment.

  1998cited by this paper
• Base-calling of automated sequencer traces using phred. II. Error probabilities.

  1998cited by this paper
• Target site selection in transposition.

  1997cited by this paper
• Bacterial phospholipases and their role in virulence.

  1997cited by this paper
• Interruption of the gpxA gene increases the sensitivity of Neisseria meningitidis to paraquat

  1996cited by this paper
• beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress.

  1995cited by this paper
• Phospholipid degradation in hypoxic/reoxygenated cardiomyocytes in response to phospholipase C from Bacillus cereus.

  1995cited by this paper
• Revival and identification of bacterial spores in 25- to 40-million-year-old Dominican amber.

  1995cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Messenger Ribonucleic Acid of Dormant Spores of Bacillus subtilis

  1974cited by this paper
• Biochemical Studies of Bacterial Sporulation and Germination XIII. Adenylate Kinase of Vegetative Cells and Spores of Bacillus subtilis

  1969cited by this paper
• Control of Fatty Acid Metabolism I. Induction of the Enzymes of Fatty Acid Oxidation in Escherichia coli

  1969cited by this paper
• Biochemical studies of bacterial sporulation and germination. X. Ribosomes and nucleic acids of vegetative cells and spores of Bacillus megaterium.

  1968cited by this paper

• Engineered bacteria for cancer therapy: Advancements, challenges, and future directions

  2025cites this paper
• Anti-Cancer Strategies Using Anaerobic Spore-Forming Bacteria Clostridium: Advances and Synergistic Approaches

  2025cites this paper
• Neutrophil Dynamics in Response to Cancer Therapies

  2025cites this paper
• Oncolytic bacteria: A revolutionary approach to cancer therapy

  2025cites this paper
• Designing live bacterial therapeutics for cancer.

  2025cites this paper
• Bacteria-based immunosuppressive tumor microenvironment reprogramming: a promising dawn in cancer therapy

  2025cites this paper
• Bacteria-Based Nanoprobes for Cancer Therapy

  2024cites this paper
• Beyond Tumor Borders: Intratumoral Microbiome Effects on Tumor Behavior and Therapeutic Responses

  2024cites this paper
• The ability of clostridium novyi-NT spores to induce apoptosis via the mitochondrial pathway in mice with HPV-positive cervical cancer tumors derived from the TC-1 cell line

  2024cites this paper
• Anaerobic bacterial metabolism responsive microspheres for bacterial embolization cancer therapy.

  2024cites this paper
• Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy

  2024cites this paper
• Personalised medicine based on host genetics and microbiota applied to colorectal cancer.

  2024cites this paper
• Recent Advances in Bacterium‐Based Therapeutic Modalities for Melanoma Treatment

  2024cites this paper
• Advances in Nanomaterials for Immunotherapeutic Improvement of Cancer Chemotherapy.

  2024cites this paper
• Hypoxia-Targeting Bacteria in Cancer Therapy.

  2024cites this paper
• Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?

  2024cites this paper
• The role of extratumoral and intratumoral microorganisms in cancer immunotherapy

  2023cites this paper
• Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies.

  2023cites this paper
• A design of experiments screen reveals that Clostridium novyi-NT spore germinant sensing is stereoflexible for valine and its analogs

  2023cites this paper
• Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context

  2023cites this paper
• Therapeutic Potential of Clostridium novyi NT in Cancer: Current Knowledge and Future Perspectives.

  2023cites this paper
• Using bugs as drugs: administration of bacteria-related microbes to fight cancer.

  2023cites this paper
• Multifunctional porous microspheres encapsulating oncolytic bacterial spores and their potential for cancer immunotherapy.

  2023cites this paper
• Fundamentals of utilizing microbes in advanced cancer therapeutics: current understanding and potential applications.

  2023cites this paper
• Anti-tumor Effects of Cisplatin Synergist in Combined Treatment with Clostridium novyi-NT Spores Against Hypoxic Microenvironments in a Mouse Model of Cervical Cancer Caused by TC-1 Cell Line

  2023cites this paper
• Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria

  2023cites this paper
• All-natural 5-MeO-DMT sigma receptor 1 agonist and its therapeutic impact in mental and neurodegener-ative diseases through mitochondrial activation

  2023cites this paper
• An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic

  2023cites this paper
• Utilizing Bacteria-Derived Components for Cancer Immunotherapy

  2022cites this paper
• Engineered microbes for cancer immunotherapy

  2022cites this paper
• Dressing Bacteria With a Hybrid Immunoactive Nanosurface to Elicit Dual Anticancer and Antiviral Immunity

  2022cites this paper
• Recent Progress and Trends in X-ray-Induced Photodynamic Therapy with Low Radiation Doses.

  2022cites this paper
• Bacteria-mediated cancer therapy: A versatile bio-sapper with translational potential

  2022cites this paper
• Novel molecules as the emerging trends in cancer treatment: an update

  2022cites this paper
• The Evolving Role of Nanoparticles in Bacteria Mediated Cancer Therapy

  2021cites this paper
• Innovative Approaches of Engineering Tumor-Targeting Bacteria with Different Therapeutic Payloads to Fight Cancer: A Smart Strategy of Disease Management

  2021cites this paper
• Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy.

  2021cites this paper
• Emerging Applications of Bacteria as Antitumor Agents.

  2021cites this paper
• Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy.

  2021cites this paper
• Dynamic Nanoassemblies of Nanomaterials for Cancer Photomedicine.

  2021cites this paper
• Neutrophil depletion enhanced the Clostridium novyi-NT therapy in mouse and rabbit tumor models

  2021cites this paper
• Methods and Techniques to Facilitate the Development of Clostridium novyi NT as an Effective, Therapeutic Oncolytic Bacteria

  2021influential citation
• Bacteria‐Based Cancer Immunotherapy

  2021cites this paper
• Metabolic regulation on the Immune Environment of Glioma through Gut Microbiota.

  2021cites this paper
• Single-celled bacteria as tool for cancer therapy

  2021cites this paper
• Levels and Characteristics of mRNAs in Spores of Firmicute Species

  2021influential citation
• Customized materials-assisted microorganisms in tumor therapeutics.

  2021cites this paper
• Tweak to Treat: Reprograming Bacteria for Cancer Treatment.

  2020cites this paper
• Bacterial Spore mRNA – What’s Up With That?

  2020influential citation
• Novel insights into the role of Clostridium novyi-NT related combination bacteriolytic therapy in solid tumors

  2020cites this paper
• Drug delivery in tumors is enhanced by bacterial proteolytic activity in a size, pharmacokinetic, and binding affinity dependent manner - A mechanistic understanding.

  2020cites this paper
• Comparative Genome Analysis and Phenotypic Characterization of Clostridium gasigenes CGAS001 Isolated From Chilled Vacuum-Packed Lamb Meat

  2020cites this paper
• Tumor Microenvironment Targeting Nano–Bio Emulsion for Synergistic Combinational X‐Ray PDT with Oncolytic Bacteria Therapy

  2020cites this paper
• Analysis of 5'-NAD capping of mRNAs in dormant spores of Bacillus subtilis.

  2020cites this paper
• Integrative Analysis of Proteome and Transcriptome Dynamics during <named-content content-type='genus-species'>Bacillus subtilis</named-content> Spore Revival

  2020cites this paper
• Characterization of Clostridium novyi isolated from a sow in a sudden death case in Korea

  2020cites this paper
• Genomics of the Pathogenic Clostridia

  2019cites this paper
• Integrative Analysis of Proteome and Transcriptome Dynamics during Bacillus subtilis Spore Revival

  2019cites this paper
• Spores and Their Significance

  2019cites this paper
• Drug delivery in tumors is enhanced by bacterial proteolytic activity in a size and binding affinity dependent manner -A mechanistic understanding

  2019cites this paper
• Analysis of the mRNAs in Spores of Bacillus subtilis

  2019cites this paper
• Genome-wide discovery of structured noncoding RNAs in bacteria

  2019cites this paper
• Iron-Oxide Nanocluster Labeling of Clostridium novyi-NT Spores for MR Imaging-Monitored Locoregional Delivery to Liver Tumors in Rat and Rabbit Models.

  2019cites this paper
• Properties of Aged Spores of Bacillus subtilis

  2019cites this paper
• Bacteria in Cancer Therapeutics: A Framework for Effective Therapeutic Bacterial Screening and Identification

  2019cites this paper
• Observations on research with spores of Bacillales and Clostridiales species

  2018cites this paper
• Learning from Clostridium novyi-NT: How to defeat cancer

  2018cites this paper
• Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

  2018cites this paper
• Tumour-targeting bacteria engineered to fight cancer

  2018cites this paper
• The Physiological Functions and Structural Determinants of Catalytic Bias in the [FeFe]-Hydrogenases CpI and CpII of Clostridium pasteurianum Strain W5

  2017influential citation
• Microbes and Cancer.

  2017cites this paper
• Production and Evaluation of a New Recombinant Cloning Vector for the Clostridium novyi Type B Vaccine Strain Alpha Toxin Gene

  2017cites this paper
• IMPACT OF BIOACTIVE MOLECULES SECRETED BY LACTOBACILLUS ACIDOPHILUS LA-5 ON CLOSTRIDIUM DIFFICILE VIRULENCE FACTORS

  2017cites this paper
• The Use of Next-Generation Sequencing in the Identification of a Fastidious Pathogen: A Lesson From a Clinical Setup

  2017cites this paper
• Branched Gold Nanoparticle Coating of Clostridium novyi-NT Spores for CT-Guided Intratumoral Injection.

  2017cites this paper
• Clostridium novyi-NT in cancer therapy

  2016influential citation
• Changes in Bacillus Spore Small Molecules, rRNA, Germination, and Outgrowth after Extended Sublethal Exposure to Various Temperatures: Evidence that Protein Synthesis Is Not Essential for Spore Germination

  2016cites this paper
• Transcriptome analysis of Bacillus thuringiensis spore life, germination and cell outgrowth in a vegetable-based food model.

  2016cites this paper
• Clostridium perfringens Sporulation and Sporulation-Associated Toxin Production

  2016cites this paper
• Correlation between genomic analyses with metatranscriptomic study reveals various functional pathways of Clostridium sartagoforme AAU1, a buffalo rumen isolate

  2016cites this paper
• Identification of CdnL, a Putative Transcriptional Regulator Involved in Repair and Outgrowth of Heat-Damaged Bacillus cereus Spores

  2016cites this paper
• Clostridium novyi-NT can cause regression of orthotopically implanted glioblastomas in rats

  2015cites this paper
• Spore Germination

  2015cites this paper
• Engineering Clostridium acetobutylicum to permit simultaneous utilization of glucose and xylose: elimination of carbon catabolite repression

  2015cites this paper
• Local bacteria affect the efficacy of chemotherapeutic drugs

  2015cites this paper
• Role of nontoxigenic Clostridium novyi in solid tumor therapy

  2014cites this paper
• Plasmidome Interchange between Clostridium botulinum, Clostridium novyi and Clostridium haemolyticum Converts Strains of Independent Lineages into Distinctly Different Pathogens

  2014cites this paper
• Elucidation of Operon Structures across Closely Related Bacterial Genomes

  2014cites this paper
• New Insights into Clostridia Through Comparative Analyses of Their 40 Genomes

  2014cites this paper
• Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo

  2014cites this paper
• Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses

  2014cites this paper
• Harnessing the Power of Microbes as Therapeutics: Bugs as Drugs

  2014cites this paper
• Structural and Functional Studies of Proteins in the Class Ib Ribonucleotide Reductase System

  2014cites this paper
• Whole-genome analysis of sporulation and germination in Clostridium difficile

  2014cites this paper
• Transcriptional Analysis of Temporal Gene Expression in Germinating Clostridium difficile 630 Endospores

  2013cites this paper
• Noninvasive imaging of infection after treatment with tumor‐homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI

  2013cites this paper
• Evolution and assembly of the ribosome

  2013cites this paper
• Array-based transcriptional analysis of Clostridium sporogenes UC9000 during germination, cell outgrowth and vegetative life.

  2013influential citation
• Effect of an Oxygen-Tolerant Bifurcating Butyryl Coenzyme A Dehydrogenase/Electron-Transferring Flavoprotein Complex from Clostridium difficile on Butyrate Production in Escherichia coli

  2013cites this paper
• A genomic approach to the cryptic secondary metabolome of the anaerobic world.

  2013cites this paper